| Market Cap | 5.41M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -529.29k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 14.00% |
| Sales | 6.56M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 6.00% |
| Dividend | N/A | Price/Book | 2.17 | EPS next 5Y | - | 52W High Chg | -22.00% |
| Recommedations | - | Quick Ratio | 0.91 | Shares Outstanding | 11.88M | 52W Low Chg | 84.00% |
| Insider Own | 43.65% | ROA | -7.83% | Shares Float | 5.23M | Beta | 0.55 |
| Inst Own | 8.12% | ROE | -25.04% | Shares Shorted/Prior | 337/120 | Price | 0.46 |
| Gross Margin | 49.00% | Profit Margin | -8.06% | Avg. Volume | 4,603 | Target Price | - |
| Oper. Margin | 1.74% | Earnings Date | Nov 12 | Volume | 1,100 | Change | 0.00% |
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It operates through two segments, Product and Service. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. It also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; AEM EndoShield 2 burn protection systems; AEM 2X enTouch scissors; and electrical engineering activities for external entities. In addition, the company markets AEM monitor product line that is used in conjunction with AEM instruments. It sells its products through a network of direct and independent sales representatives. The company was formerly known as Electroscope Inc and changed its name to Encision Inc. in August 2000. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| FRIES ROBERT H | Director Director | Nov 16 | Buy | 0.45 | 25,000 | 11,250 | 580,000 | 11/18/22 |
| Geary Peter D | Dir of Strategic Int.. Dir of Strategic Integration | Jul 08 | Buy | 0.41 | 40,000 | 16,400 | 40,000 | 07/20/22 |
| Trudel Gregory J. | CEO CEO | Sep 15 | Option | 0.31 | 75,000 | 23,250 | 75,000 | 09/15/21 |